Chargement de la fiche…
Chargement de la fiche…
rhumatologie
Praticien hospitalier
Paris 14e Arrondissement (75679)
Vasculitis and related conditions · Otitis Media and Relapsing Polychondritis · Rheumatoid Arthritis Research and Therapies
Tout est calculé à partir des sources publiques (RPPS, PubMed, OpenAlex, OpenStreetMap…) — aucun classement éditorial.
2018–2024
Centre National de la Recherche Scientifique
2013–2024
Inserm
2023
European Organisation for Rare Diseases
2010–2022
Délégation Paris 5
2021
Apple (Israel)
2013–2015
Centre National de la Recherche Scientifique
0
h-index
0
i10
0
citations
Le h-index mesure la productivité scientifique : ce médecin a publié 73 articles cités au moins 73fois par d'autres chercheurs. Plus c'est élevé, plus son travail influence la communauté médicale.
Côté patient
Comprendre votre pathologie, exercices à domicile, applications validées, paramédicaux à proximité — gratuit, sans inscription.
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'Études Spécialisées
DE Docteur en médecine — Capacité / Certificat d'Études Spéciales
0
travaux
0
h-index
0
i10-index
0
citations
2026European journal of internal medicine
PubMed ↗Clinically isolated joint involvement is a distinct entity in Whipple's disease
2026Joint bone spine
PubMed ↗French recommendations for the use of imaging in giant cell arteritis
2026European journal of internal medicine
PubMed ↗Identifying distinct clinical phenotypes and outcomes in adult-onset IgA vasculitis using unsupervised clustering analysis
2026Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗Antineutrophil Cytoplasmic Antibody-Associated Vasculitides in Systemic Sclerosis: A Unique Clinical Overlap With Significant Implications for Treatment and Outcomes
2026American journal of respiratory and critical care medicine
PubMed ↗Plasma exchange for severe alveolar hemorrhage in antineutrophil cytoplasmic antibody-associated vasculitis: emulation of a target trial
2026The Journal of rheumatology
PubMed ↗Spondylodiscitis Caused by Tropheryma whipplei: Report of 2 Cases
2026Journal of internal medicine
PubMed ↗Overlapping forms of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis: Insights from a European multicenter study
2026Rheumatology (Oxford, England)
PubMed ↗Polyarteritis nodosa associated with VEXAS syndrome and chronic myelomonocytic leukemia: a case-control study
2026Journal of human immunity
PubMed ↗IRF4 haploinsufficiency in a multiplex family with Whipple's disease
2025Rheumatology (Oxford, England)
PubMed ↗Glucocorticoids vs glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis without poor-prognosis factors: a target trial emulation study
2025Rheumatology (Oxford, England)
PubMed ↗Early progression of capillaritis manifestations and poor renal outcome after induction therapy failure in microscopic polyangiitis
2025RMD open
PubMed ↗Concordance between presenting features and relapse in granulomatosis with polyangiitis: implications for risk assessment and counselling
2025Kidney international reports
PubMed ↗Effect of Baseline Dialysis and Plasma Exchange on Renal Prognosis in Patients With Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis
2025The Lancet. Infectious diseases
PubMed ↗Whipple's disease: from in-vitro data to bedside practice via trial results
2024Journal of autoimmunity
PubMed ↗Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors
2024Rheumatology (Oxford, England)
PubMed ↗Dysregulation of neutrophil oxidant production and interleukin-1-related cytokines in granulomatosis with polyangiitis
2023Annals of the rheumatic diseases
PubMed ↗Benralizumab for eosinophilic granulomatosis with polyangiitis
2023Journal of autoimmunity
PubMed ↗Clinical features and long-term outcomes of patients with systemic polyarteritis nodosa diagnosed since 2005: Data from 196 patients
2023Rheumatology (Oxford, England)
PubMed ↗Clinico-radiological correlation and prognostic value of baseline chest computed tomography in eosinophilic granulomatosis with polyangiitis
2023Revue des maladies respiratoires
PubMed ↗[Anti-IL-5 in severe asthma associated with eosinophilic granulomatosis with polyangiitis. Real-life study]
2023Rheumatology (Oxford, England)
PubMed ↗Induction failure in granulomatosis with polyangiitis: a nationwide case-control study of risk factors and outcomes
2023Annals of the rheumatic diseases
PubMed ↗Finger ischaemia, enlarged spleen and lung nodules
2026Clinical journal of the American Society of Nephrology : CJASN
PubMed ↗Kidney Transplantation in Childhood-Onset ANCA-Associated Vasculitis: Long-Term Outcomes and Prognostic Factors
2025EBioMedicine
PubMed ↗Comparison of rituximab induction and maintenance regimens in anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: PK/PD modelling of ANCA and gammaglobulin levels in real-world patients
2025Clinical reviews in allergy & immunology
PubMed ↗Glandular Manifestations of the Head and Neck in ANCA-Associated Vasculitides: Data from a National Cohort and Systematic Review
2025Joint bone spine
PubMed ↗Update on targeted treatments for ANCA-associated vasculitis
2025The Lancet. Rheumatology
PubMed ↗Older age and frailty in ANCA-associated vasculitis: the thin line between undertreating and overtreating
2025La Revue du praticien
PubMed ↗[Recent developments in the treatment of ANCA-associated vasculitides]
2024The Lancet. Rheumatology
PubMed ↗Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort
2024Seminars in arthritis and rheumatism
PubMed ↗Large-vessel involvement in ANCA-associated vasculitis: A multicenter case-control study
2024Rheumatology (Oxford, England)
PubMed ↗Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicentre retrospective case-control study
2024Clinical journal of the American Society of Nephrology : CJASN
PubMed ↗Race, Ethnicity, Sex, Gender, Socioeconomic Status, and Representativeness of Race and Ethnicity in ANCA Vasculitis Randomized Trials
2024Rheumatology (Oxford, England)
PubMed ↗ANCA-associated scleritis: impact of ANCA on presentation, response to therapy and outcome
2024Annals of the rheumatic diseases
PubMed ↗Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials
2024Annals of the rheumatic diseases
PubMed ↗Data quality and patient characteristics in European ANCA-associated vasculitis registries: data retrieval by federated querying
2024Journal of autoimmunity
PubMed ↗Risk factors for hypogammaglobulinemia and association with relapse and severe infections in ANCA-associated vasculitis: A cohort study
2023Autoimmunity reviews
PubMed ↗Characteristics of ANCA-associated vasculitis with aneurysms: Case series and review of the literature
2023The journal of allergy and clinical immunology. In practice
PubMed ↗Identification of EPX Variants in Human Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)
2025Annals of internal medicine
PubMed ↗Rituximab Versus Conventional Therapy for Remission Induction in Eosinophilic Granulomatosis With Polyangiitis : A Randomized Controlled Trial
2025EBioMedicine
PubMed ↗Comparison of rituximab induction and maintenance regimens in anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: PK/PD modelling of ANCA and gammaglobulin levels in real-world patients
2024Annals of the rheumatic diseases
PubMed ↗Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials
2023RMD open
PubMed ↗Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study
2023Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗Association Between Plasma Rituximab Concentration and the Risk of Major Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides During Rituximab Maintenance Therapy
2025Seminars in arthritis and rheumatism
PubMed ↗Treatment strategies and outcomes in adult relapsing or refractory cutaneous IgA Vasculitis: A multicenter retrospective cohort study
2025European journal of internal medicine
PubMed ↗Isolated joint involvement in Whipple's disease: a cohort study
2024The Journal of infection
PubMed ↗Diagnosis and treatment of Tropheryma whipplei infection in patients with inflammatory rheumatic disease: Data from the French Tw-IRD registry
2023Arthritis care & research
PubMed ↗Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual
2026Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗Prediction of Relapse and Glucocorticoid Dependence in Eosinophilic Granulomatosis With Polyangiitis: Findings From a Large European Cohort
2025Annals of the rheumatic diseases
PubMed ↗Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitis
2025Rheumatology (Oxford, England)
PubMed ↗Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: a multicentre retrospective study
2025Respirology case reports
PubMed ↗Management of Subglottic Stenosis With Tracheostomy in a Surgical Candidate Patient With Granulomatosis With Polyangiitis: A Case Report
2026The Journal of rheumatology
PubMed ↗Trends in Patient Accrual Rates, Screening Failures, and Related Reasons in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Randomized Controlled Trials
2025Kidney international reports
PubMed ↗Explainability of a Deep Learning-Based Classification Model for Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis
2024Rheumatology (Oxford, England)
PubMed ↗Combining ts- and a bDMARD in refractory rheumatoid arthritis: an unusual adverse event
2026Autoimmunity
PubMed ↗IgA Vasculitis with necrotizing arteritis: a multicenter retrospective study from the French Vasculitis Study Group and systematic review of the literature
2026Autoimmunity
PubMed ↗IgA Vasculitis with necrotizing arteritis: a multicenter retrospective study from the French Vasculitis Study Group and systematic review of the literature
2026Article
IgA Vasculitis with necrotizing arteritis: a multicenter retrospective study from the French Vasculitis Study Group and systematic review of the literature
Autoimmunity
2026Article
Plasma exchange for severe alveolar hemorrhage in ANCA-associated vasculitis: emulation of a target trial
American Journal of Respiratory and Critical Care Medicine
2026Article
Identifying distinct clinical phenotypes and outcomes in adult-onset IgA vasculitis using unsupervised clustering analysis
European Journal of Internal Medicine
2026Article
IRF4 haploinsufficiency in a multiplex family with Whipple’s disease
Journal of Human Immunity
2026Article
Prediction of Relapse and Glucocorticoid Dependence in Eosinophilic Granulomatosis With Polyangiitis: Findings From a Large European Cohort
Arthritis & rheumatology
2025Article
Concordance between presenting features and relapse in granulomatosis with polyangiitis: implications for risk assessment and counselling
RMD Open
2025Article
Effect of Baseline Dialysis and Plasma Exchange on Renal Prognosis in Patients With Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
Kidney International Reports
2025Congrès
Impact and risk factors of anti-rituximab antibodies in small-vessel vasculitis: a multicenter retrospective study
ACR Convergence 2025
▶Webconference du Pr Xavier Puechal sur les pathologies pouvant mimer une vascularite
GFEV Fonds IMMUNOV
▶Pathologies pouvant mimer une vascularite systémique
Filière de santé FAI²R
▶Granulomatose avec polyangéite, polyangéite microscopique : Actualités 2024
Xavier Puechal
▶Vascularites systémiques Diagnostic et conduite à tenir Pr Guillevin
Xavier Puechal
▶Manifestations ORL de la Granulomatose avec polyangéite Wegener Pr Guillevin
Xavier Puechal
▶Actualités au congrès de l'ACR 2022 - Dr Xavier Puéchal
GFEV Fonds IMMUNOV